Stay updated on ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial
Sign up to get notified when there's something new on the ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial page.

Latest updates to the ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check12 days agoChange DetectedThe web page has been updated to reflect a new study on ALT-801 (pemvidutide) in healthy overweight and obese volunteers, including detailed descriptions of the study's phases and participant criteria. The previous study results and dates have been removed, indicating a shift in focus to the current study's design and objectives.SummaryDifference34%
- Check19 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
Stay in the know with updates to ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial page.